Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Towards quality indicators in palliative care education: An umbrella review.

Palliative care and social practice·2026
Same author

The Association Between Inflammatory Scores and Frailty Severity: An Exploratory Retrospective Analysis in Non-Small-Cell Lung Cancer Surgical Patients.

Medical sciences (Basel, Switzerland)·2026
Same author

Itepekimab for chronic obstructive pulmonary disease therapy.

Expert opinion on biological therapy·2026
Same author

Risk Stratification for Postoperative Mortality in Cardiac Surgery: "Quo Vadis"?

Medicina (Kaunas, Lithuania)·2026
Same author

Short-acting beta 2 agonists overuse in asthma: where are we now?

Expert opinion on drug safety·2026
Same author

Tarlatamab for small-cell lung cancer.

Expert opinion on biological therapy·2025

Related Experiment Video

Updated: May 15, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Tralokinumab for uncontrolled asthma.

Ileana Antohe1, Rodica Croitoru, Sabina Antoniu

  • 1University of Medicine and Pharmacy, Grigore T Popa Iaşi, Internal Medicine I Clinic, Emergency Hospital Saint Spiridon, Independence Boulevard 1, 700019, Iasi, Romania.

Expert Opinion on Biological Therapy
|December 28, 2012
PubMed
Summary
This summary is machine-generated.

Targeting interleukin-13 (IL-13) with therapies like tralokinumab shows promise for asthma. This approach is most effective in asthma patients with high IL-13 levels, improving disease control.

More Related Videos

Non-Invasive Endotracheal Administration of Lipopolysaccharide to Induce Acute Lung Injury in Rodents
04:10

Non-Invasive Endotracheal Administration of Lipopolysaccharide to Induce Acute Lung Injury in Rodents

Published on: December 5, 2025

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

Related Experiment Videos

Last Updated: May 15, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Non-Invasive Endotracheal Administration of Lipopolysaccharide to Induce Acute Lung Injury in Rodents
04:10

Non-Invasive Endotracheal Administration of Lipopolysaccharide to Induce Acute Lung Injury in Rodents

Published on: December 5, 2025

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

Area of Science:

  • Immunology
  • Pulmonology
  • Pharmacology

Background:

  • Asthma is a chronic airway inflammatory disease.
  • Allergen exposure triggers cytokine pathways promoting IgE hyperproduction, bronchial hyperresponsiveness, eosinophil recruitment, and airway remodeling.
  • Interleukin-13 (IL-13) plays a significant role in asthma pathogenesis.

Purpose of the Study:

  • To discuss the efficacy of anti-IL-13 antibody therapies in asthma.
  • To evaluate the potential of tralokinumab in uncontrolled asthma patients.

Main Methods:

  • Review of a Phase II clinical study involving tralokinumab, a human IgG4 anti-IL-13 antibody.
  • Analysis of patient subsets based on sputum IL-13 levels.

Main Results:

  • Tralokinumab demonstrated maximal efficacy in a specific subset of asthma patients.
  • This subset was characterized by the highest sputum IL-13 levels.

Conclusions:

  • Blocking IL-13 with therapies like tralokinumab can improve asthma control.
  • Therapeutic efficacy is linked to the overexpression of IL-13 in specific patient populations.